213 related articles for article (PubMed ID: 20015465)
1. Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves' disease.
Kuang M; Wang S; Wu M; Ning G; Yao Z; Li L
Mol Cell Endocrinol; 2010 May; 319(1-2):23-9. PubMed ID: 20015465
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
Pichurin P; Pham N; David CS; Rapoport B; McLachlan SM
Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and discrimination of autoimmune Graves' disease and Hashimoto's disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes.
Fukushima H; Matsuo H; Imamura K; Morino K; Okumura K; Tsumoto K; Yoshimura T
J Biosci Bioeng; 2009 Dec; 108(6):551-6. PubMed ID: 19914592
[TBL] [Abstract][Full Text] [Related]
4. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
[TBL] [Abstract][Full Text] [Related]
5. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
Li CW; Osman R; Menconi F; Concepcion E; Tomer Y
J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b.
Pichurin P; Chen CR; Pichurina O; David C; Rapoport B; McLachlan SM
Thyroid; 2003 Oct; 13(10):911-7. PubMed ID: 14611699
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
[No Abstract] [Full Text] [Related]
8. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune thyroid disease--a perspective.
Volpé R
Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
[TBL] [Abstract][Full Text] [Related]
10. The significance of immune-related molecule expression profiles in an animal model of Graves' disease.
Ye F; Hou P; Wu X; Ma X; Gao L; Wu L; Xu L; Shi B
Autoimmunity; 2012 Mar; 45(2):143-52. PubMed ID: 22017306
[TBL] [Abstract][Full Text] [Related]
11. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
Morshed SA; Ando T; Latif R; Davies TF
Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
[TBL] [Abstract][Full Text] [Related]
12. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule.
Sawai Y; DeGroot LJ
J Clin Endocrinol Metab; 2000 Mar; 85(3):1176-9. PubMed ID: 10720058
[TBL] [Abstract][Full Text] [Related]
13. Genetics of thyroid autoimmunity and the role of the TSHR.
Brand OJ; Gough SC
Mol Cell Endocrinol; 2010 Jun; 322(1-2):135-43. PubMed ID: 20083159
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells in Graves' disease.
Purnamasari D; Soewondo P; Djauzi S
Acta Med Indones; 2015 Jan; 47(1):61-9. PubMed ID: 25948770
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
18. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
Nagataki S
Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
[TBL] [Abstract][Full Text] [Related]
19. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
20. Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity.
Stefan M; Wei C; Lombardi A; Li CW; Concepcion ES; Inabnet WB; Owen R; Zhang W; Tomer Y
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12562-7. PubMed ID: 25122677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
